XML 451 R58.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-based compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Schedule of Share-Based Payment Arrangement By Share-Based Payment Award, Performance Criteria The table below shows the performance criteria and the corresponding weight of the LTI performance plans granted
in 2024.
LTI performance plan criteria
Market/Non-market element
Weight
Relative TSR
Market
30%
Strategic value drivers
Non-market
30%
Technology Leadership Index
Non-market
20%
ESG measures
Non-market
20%
Total
100%
Schedule of Assumptions Used for Calculation of the Fair Value of Shares The most important assumptions for the calculation of the fair value of shares for the LTI performance plans, which
include market-based performance criteria, are set out in the following table:
Year ended December 31
2022
2023
2024
Share price in € at grant date
548.0
620.1
707.1
Expected volatility ASML
41.8%
46.2%
40.0%
Average volatility of the peer group (market practice)
47.8%
50.0%
43.3%
Vesting period
2.7 years
2.9 years
2.9 years
Dividend yield
1.0%
0.9%
0.7%
Risk free interest rate (Eurozone)
0.5%
2.4%
2.4%
Risk free interest rate (U.S.)
2.8%
3.9%
4.2%
Schedule of Expenses for Share Plans An overview of the incurred and expected expenses for the LTI plans are set out in the following table:
Year ended December 31 (€, in millions)
2022
2023
2024
Incurred expenses
68.9
134.8
172.6
Expected expenses of conditionally granted plans in future periods
113.0
187.2
246.1
Weighted average period for recognizing these expected expenses
1.4 years
1.6 years
1.5 years
Recognized income tax benefit (excluding excess income tax benefits)
10.2
16.3
28.2
Schedule of Shares Activity During Period Details with respect to shares granted and vested during the year are set out in the following table:
  
EUR-denominated
USD-denominated
Year ended December 31
2022
2023
2024
2022
2023
2024
Total fair value of shares vested during the year (in millions)
120.6
175.5
161.4
149.6
127.0
155.2
Weighted average fair value of shares granted
578.65
587.42
801.78
553.61
624.10
848.18
A summary of the status of conditionally outstanding shares as of December 31, 2024, and changes during the year
ended December 31, 2024, is presented below:
  
EUR-denominated
USD-denominated
 
Number
of shares
Weighted
average
fair value at
grant date
Number
of shares
Weighted
average
fair value at
grant date
Conditional shares outstanding at January 1, 2024
275,571
576.37
363,119
620.31
Granted
220,149
801.78
260,307
848.18
Vested
(211,517)
671.93
(201,411)
678.12
Forfeited
(3,850)
667.89
(11,335)
688.73
Conditional shares outstanding at December 31, 2024
280,353
680.02
410,680
734.50
Details with respect to stock options exercised and outstanding are set out in the following table:
  
EUR-denominated
USD-denominated
Year ended December 31
2022
2023
2024
2022
2023
2024
Weighted average share price at stock option exercise
494.14
613.03
834.48
565.39
678.41
911.23
Aggregate intrinsic value of exercised stock options (in millions)
4.4
8.1
10.2
1.6
4.8
8.2
Weighted average remaining contractual term of exercisable
options (in years)
2.08
1.48
0.83
2.09
1.43
0.84
Aggregate intrinsic value of exercisable stock options (in millions)
20.3
19.7
11.4
14.6
15.9
8.2
Aggregate intrinsic value of outstanding stock options (in millions)
20.3
19.7
11.4
14.6
15.9
8.2
Schedule of Number and Weighted Average Exercise Prices of Stock Options Activity The number and weighted average exercise prices of stock options as of December 31, 2024, and changes during
the year then ended are presented below:
  
 EUR-denominated
USD-denominated
 
Number
of options
Weighted
average exercise
price per ordinary
share (in €)
Number
of options
Weighted
average exercise
price per ordinary
share (in $)
Outstanding, January 1, 2024
32,839
82.52
23,962
94.01
Granted1
Exercised
(13,471)
75.44
(10,048)
91.90
Forfeited
Expired
(32)
64.39
(180)
92.23
Outstanding, December 31, 2024
19,336
87.48
13,734
95.58
Exercisable, December 31, 2024
19,336
87.48
13,734
95.58
1.Since 2017, we no longer grant options to our employees.
Schedule of Range of Exercise Prices, Number of Outstanding Options, and Weighted Average Remaining Contractual Life of Oustanding Options Details with respect to stock options exercised in the relevant year and outstanding stock options as of December
31, 2024, are set out in the following table:
EUR-denominated
USD-denominated
Range of exercise
prices (in €)
Number of
outstanding options
Weighted average
remaining
contractual life of
outstanding (years)
Range of exercise
prices (in $)
Number of
outstanding options
Weighted average
remaining
contractual life of
outstanding (years)
7080
3,864
0.79
7080
0.00
8090
7,761
0.89
8090
2,843
0.79
90100
7,711
0.79
90100
6,382
0.84
100110
0.00
100110
4,509
0.87
Total
19,336
0.83
Total
13,734
0.84